SCHEMBL9032111

SCHEMBL9032111

O=c1[nH]c(=O)n(Cc2ccccc2)c2nc[nH]c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNP P00491 2/20 1.00
PDE4A P27815 5/20 0.64
PDE4B Q07343 5/20 0.64
PDE4C Q08493 5/20 0.64
PDE4D Q08499 5/20 0.64
ADORA2A P29274 3/20 0.64
ADORA3 P0DMS8 2/20 0.61
ADORA2B P29275 2/20 0.61
HPGD P15428 1/20 0.61
ADORA1 P30542 1/20 0.61
BLM P54132 1/20 0.61
PDE3A Q14432 1/20 0.61
HSD17B10 Q99714 1/20 0.61
MPO P05164 1/20 0.60
TPO P07202 1/20 0.60
KMT2A Q03164 1/20 0.56
BRD4 O60885 1/20 0.53
TLR7 Q9NYK1 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27859109 0.89 PNP (0.79) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL7681629 0.89 PNP (0.80) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL9031047 0.86 PNP (0.75) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL28874054 0.84 PNP (0.72) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL985624 0.80 PNP (0.66) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL3107001 0.79 ADORA3 (0.78) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL5515323 0.78 ADORA2A (0.71) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL7466316 0.78 ADORA2A (1.00) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL1461128 0.77 PNP (0.62) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL6360066 0.77 ADORA2B (0.75) PNPPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109796453-A A kind of preparation method of 1,7- dimethyl xanthine 南京纽邦生物科技有限公司 2019-05-24 CN disclosed
EP-0417790-B1 S-triazolo[3,4-i]purine derivatives KYOWA HAKKO KOGYO KK (JP) 1996-12-04 EP disclosed
EP-0528164-B1 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata HOECHST AG (DE) 1996-05-29 EP disclosed
US-5409935-A Inhibit formation of free radicals HOECHST AKTIENGESELLSCHAFT (DE) 1995-04-25 US disclosed
EP-0369744-B1 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-09-21 EP disclosed
US-5321029-A Vascular and skin disorders; bronchodilator BEECHAM-WUELFING GMBH & CO.K.G. (DE) 1994-06-14 US disclosed
EP-0319854-B1 Process for the methylation of xanthins BOEHRINGER INGELHEIM KG (DE) 1994-03-02 EP disclosed
US-5270316-A Condensed purine derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-12-14 US disclosed
EP-0528164-A2 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata HOECHST AKTIENGESELLSCHAFT (DE) 1993-02-24 EP disclosed
US-5173492-A Bronchodilator agents KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-12-22 US disclosed
EP-0423805-A2 Condensed purine derivatives KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1991-04-24 EP disclosed
EP-0417790-A2 S-triazolo[3,4-i]purine derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-03-20 EP disclosed
EP-0369744-A2 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GmbH (DE) 1990-05-23 EP disclosed
EP-0319854-A2 Process for the methylation of xanthins BOEHRINGER INGELHEIM KG (DE) 1989-06-14 EP disclosed
EP-0260127-A2 Xanthine derivatives, their preparation and pharmaceutical compositions containing them BEECHAM - WUELFING GmbH & Co. KG (DE) 1988-03-16 EP disclosed